Gritstone Oncology Inc (NASDAQ:GRTS)

Delayed Data
As of Mar 27
 -0.64 / -10.49%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Gritstone Oncology Inc have a median target of 20.00, with a high estimate of 31.00 and a low estimate of 16.00. The median estimate represents a +266.30% increase from the last price of 5.46.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Gritstone Oncology Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.19%
Growthannually 0.27%


Growthquarterly 41.87%
Growthannually 13.89%
Key to the earnings and sales forecast charts.